Weekly Reader - December 5, 2022

Welcome to Finestra’s Weekly Reader, wherein we recount intriguing, important, or infamous health care-related stories you may have missed over the past week

Weekly Reader - December 5, 2022
Photo by Maria Vojtovicova / Unsplash

Welcome to Finestra’s Weekly Reader, wherein we recount intriguing, important, or infamous health care-related stories you may have missed over the past week.

  • Pfizer’s Covid Cash Powers a ‘Marketing Machine’ on the Hunt for New Supernovas. (Kaiser Health News) "For drugmaker Pfizer, a fortune amassed in the covid pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions."
  • Monkeypox Has a New Name: Mpox. (New York Times) “Health experts said the old nomenclature was imprecise, played into racist stereotypes and fueled stigmatization, making it harder to contain the most recent outbreaks.”
  • Defense Department Health Plan Cuts Its Pharmacy Network by Nearly 15,000 Outlets. (Kaiser Health News) "About 27% of all pharmacies in the Tricare network are no longer covered, leaving more than 400,000 military beneficiaries affected."
  • Covid deaths skew older, reviving questions about ‘acceptable loss’. (The Washington Post) “The pandemic has become a plague of the elderly, with nearly 9 out of 10 deaths in people 65 or older.”
  • People With Long Covid Face Barriers to Government Disability Benefits. (Kaiser Health News) "People are facing years-long wait times, insufficient legal support, and a lack of clear guidance on how to prove they are disabled — compounded by the challenges of a medical system that does not have a uniform process for diagnosing long covid, according to health experts and disability attorneys."
  • Why the US is having shortages of antibiotics now. (CNN) “Remember the shortages of personal protective equipment in March 2020? Now it's medications for kids.”